A Pilot Randomized Trial of Personal Genomics for Preventive Cardiology
The purpose of this study is to see if providing information to a person on their inherited (genetic) risk of cardiovascular disease (CVD) helps to motivate that person to change their diet, lifestyle or medication regimen to alter their risk.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- John P.A. Ioannidis
- Themistocles L. Assimes, MD PhD
- Carlos Bustamante
- Michaela Kiernan
- Euan A. Ashley
- Joshua W. Knowles
- behavioral : genetic risk score for coronary risk factors
Ages Eligible For Study:
- Adults age > 18 - Patient seeking cardiovascular risk evaluation - At intermediate (6-20%) or high risk (> 20%) over 10 years of CAD as defined by Framingham 10 year risk score AND/OR at > 20% risk of CAD over 30 years using the Framingham 30 year risk calculator - The genetic risk factors have been evaluated predominantly in white/European subjects. However, there is considerable overlap in the genetic architecture of South Asians and Hispanic/Latino populations. Therefore, we will limit our initial studies to these three race/ethnicity groups.